S.Biomedics Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	16,548	13,734	13,108	12,113	8,868
Other Revenue	-	-	-	-0	-
Revenue	16,548	13,734	13,108	12,113	8,868
Revenue Growth (YoY)	20.49%	4.77%	8.22%	36.59%	66.72%
Cost of Revenue	9,001	7,027	6,555	6,002	4,549
Gross Profit	7,547	6,707	6,554	6,111	4,319
Selling, General & Admin	5,797	5,665	5,414	4,224	3,357
Research & Development	9,179	5,850	6,508	5,489	5,525
Amortization of Goodwill & Intangibles	7.95	5.39	5.06	9.07	9.49
Operating Expenses	15,891	12,149	12,543	9,863	8,947
Operating Income	-8,344	-5,442	-5,989	-3,752	-4,628
Interest Expense	-1,451	-795.15	-883.54	-727.42	-674.93
Interest & Investment Income	369.52	310.05	266.24	146.72	101.05
Currency Exchange Gain (Loss)	-22.05	83.95	39.53	17.21	91.56
Other Non Operating Income (Expenses)	2,528	-159.85	-2,665	-918.38	-151.52
EBT Excluding Unusual Items	-6,919	-6,003	-9,232	-5,234	-5,262
Gain (Loss) on Sale of Investments	105.87	76.12	92.61	23.87	0.24
Gain (Loss) on Sale of Assets	-	-	5.49	-	-
Other Unusual Items	4.06	169.48	-0.48	-	12.82
Pretax Income	-6,809	-5,757	-9,134	-5,210	-5,249
Income Tax Expense	250.51	63.79	123.24	-455.23	-6.59
Earnings From Continuing Operations	-7,059	-5,821	-9,258	-4,755	-5,242
Minority Interest in Earnings	-1,063	-869.84	-1,063	-1,572	-424.81
Net Income	-8,122	-6,691	-10,321	-6,327	-5,667
Net Income to Common	-8,122	-6,691	-10,321	-6,327	-5,667
Shares Outstanding (Basic)	12	12	11	10	10
Shares Outstanding (Diluted)	12	12	11	10	10
Shares Change (YoY)	3.22%	5.22%	6.97%	0.67%	0.42%
EPS (Basic)	-684.07	-581.66	-944.09	-619.09	-558.24
EPS (Diluted)	-684.07	-581.66	-944.09	-619.09	-558.24
Free Cash Flow	-8,584	-4,890	-7,996	-12,501	-3,762
Free Cash Flow Per Share	-722.99	-425.15	-731.44	-1223.19	-370.56
Gross Margin	45.61%	48.84%	50.00%	50.45%	48.70%
Operating Margin	-50.42%	-39.62%	-45.69%	-30.98%	-52.19%
Profit Margin	-49.08%	-48.72%	-78.73%	-52.23%	-63.90%
Free Cash Flow Margin	-51.88%	-35.61%	-61.00%	-103.20%	-42.42%
EBITDA	-6,301	-3,717	-4,436	-2,235	-3,180
EBITDA Margin	-38.08%	-27.06%	-33.84%	-18.45%	-35.86%
D&A For EBITDA	2,043	1,725	1,553	1,517	1,448
EBIT	-8,344	-5,442	-5,989	-3,752	-4,628
EBIT Margin	-50.42%	-39.62%	-45.69%	-30.98%	-52.19%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.